Identification of microsatellite instability and mismatch repair gene mutations in breast cancer cell lines

Genes Chromosomes Cancer. 2003 May;37(1):29-35. doi: 10.1002/gcc.10196.

Abstract

At present, there is conflicting evidence whether microsatellite instability (MSI) plays a role in the pathogenesis of breast cancer. Here we describe for the first time an MSI(+) phenotype in two breast cancer cell lines, CAL51 and MT-3, resembling that observed in colorectal cancers. These cell lines are characterized by near-diploid and hyperdiploid karyotypes, respectively. We detected MSI in these cell lines within two non-coding (BAT-25 and BAT-26) and within coding repeat sequences of genes known to be mutated in MSI(+) cancer (TGFBR2, IGF2R, BAX). We provide evidence that the inactivation of MMR genes is responsible for MSI in these cell lines.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Base Pair Mismatch / genetics*
  • Breast Neoplasms / genetics*
  • Breast Neoplasms / pathology
  • DNA Mutational Analysis / methods
  • DNA Repair / genetics*
  • DNA, Neoplasm / genetics
  • Female
  • Gene Amplification / genetics
  • Gene Expression Profiling
  • Gene Expression Regulation, Neoplastic / genetics
  • Humans
  • Microsatellite Repeats / genetics*
  • Mutation / genetics*
  • Nucleic Acid Heteroduplexes / genetics
  • Ovarian Neoplasms / genetics
  • Ovarian Neoplasms / pathology
  • Phenotype
  • Polyploidy
  • Protein Serine-Threonine Kinases
  • Proto-Oncogene Proteins / genetics
  • Proto-Oncogene Proteins c-bcl-2*
  • Receptor, IGF Type 2 / genetics
  • Receptor, Transforming Growth Factor-beta Type II
  • Receptors, Transforming Growth Factor beta / genetics
  • Tumor Cells, Cultured
  • bcl-2-Associated X Protein

Substances

  • BAX protein, human
  • DNA, Neoplasm
  • Nucleic Acid Heteroduplexes
  • Proto-Oncogene Proteins
  • Proto-Oncogene Proteins c-bcl-2
  • Receptor, IGF Type 2
  • Receptors, Transforming Growth Factor beta
  • bcl-2-Associated X Protein
  • Protein Serine-Threonine Kinases
  • Receptor, Transforming Growth Factor-beta Type II